Identification of Lithocholic Acid and Measurement of Other Bile Acids in Serum of
Traces of lithocholic acid were found in 20% of the cases studied. The smaller ranges we found for serum bile acid concentrations in a healthy fasting population are attributed to the careful health-screening of subjects and improved techniques.
Additional Keyphrases: The ability to resolve complex mixtures and measure extremely small quantities of bile acids by GLC,3 in contrast to the results by earlier spectroscopic techniques, has bxought renewed optimism to this area of biomedical research (1) (2) (3) (4) (5) (6) . GLC was first used to estimate bile salts (in duodenal contents) by Blomstrand (1) from chenodeoxycholic acid by bacterial action, is present in generous quantities in human feces (7) . It is unique among the known human bile acids, possessing pyrogenic and inflammatory properties that prompted several investigators to postulate a causative role for it in certain liver diseases. The chromatographic demonstration of lithocholic acid in peripheral blood (8) has been inconclusive, because its identification has been based only on retention time; methods that would identify its molecular structure have not been used.
Our purpose was to determine by GLC-MS whether lithocholic acid is present in serum from healthy, fasting subjects.
In addition, we developed an improved purification procedure for serum analysis and verified the presence of major bile acids by combined GLC-MS before measuring them by GLC. washed four times with an excess of solution NaHCO3 (100 g/liter), and then with de-ionized water until the pH reached 7.0. The resin was then successively washed four times with absolute ethanol, hexane, absolute ethanol, and water. To convert the resin to the hydroxide form, the Amberlyst A-27 was suspended in NaOH solution (100 g/liter), washed several times with this solution, and then rinsed with water until the washings were of the same pH as the wash water.
Materials and Methods

Reagents
General procedure. 0.1 1jCi of [14Cj-24-cholic acid (specific activity 100 lLCi/mmol) was added to every serum sample to determine the overall recovery during purification.
The pH of the serum sample was adjusted to 5.6 with 0.1 molar sodium acetate buffer, and EDTA and fl-mercaptoethanol were also added. Enzymic hydrolysis was conducted as just described, except that hydrolysis was ended by increasing the pH to 11 with 1 molar NaOH.
The suspension of ion-exchange resin (about 25-30/g per column, capacity 2.5 mmol/g) was poured into a glass column (1.0 cm X 15 cm), the serum sample was quantitatively transferred onto the resin bed, and the column was washed to neutrality with de-ionized water. After successive rinsing with 80 ml of 95% ethanol, 80 ml of ethanol-ethylene dichloride (1:1 by vol), and 80 ml of 95% ethanol, the bile acids were eluted from the resin with 150 ml of 0.2 molar (NH4)2C03 in 80% ethanol, and the eluate was evaporated.
The residue was reconstituted in 20 ml of water. The pH was adjusted to 1.0 with 6 molar HC1 and the aqueous solution was extracted with six 10-ml aliquots of diethyl ether. The ether fractions were combined, dried over Na2SO4, the solvent evaporated, and the residue dissolved in 10 ml of ether plus 1 ml of methanol.
The bile acid solution was treated dropwise with diazomethane until the yellow color persisted for 15 mm, and excess solvent was removed.
The methylated bile acids were further purified by column chromatography on aluminum oxide. The alumina (2 g in a 0.8 mm X 6 cm column) was prepared as a slurry in hexane. The. bile acid residue was quantitatively transferred to the alumina column in a total of 1.0 ml of diethyl ether. After successive washing with 30 ml of hexane and 80 ml of benzene, the methylated bile acids were eluted with 40 ml of methanol-acetone mixture (1:1 by 'o1 with no carrier gas (N2) flow for 4 h and with 20 ml/min for 18 h at 245#{176}C. During analyses, flow rates for carrier gas, hydrogen, and air were 60, 55, and
GLC-MS.
A measurements. Blood samples were obtained in the morning after an overnight fast, and sera were kept frozen at -20#{176}C until analyzed. Serum (15 ml) from one of these subjects contained about equal amounts of lithocholic, chenodeoxycholic, deoxcholic, and cholic acids; this serum was used to verify by GLC-MS the individual bile acids.
Results
Hydrolysis
and recovery of bile acids. Sodium glvcocholate was used to test each new crude enzyme preparation.
We consistently observed by GLC that hydrolysis proceeded quantitatively to cholic acid and that no other products appeared in these chromatograms.
With use of [14C]-24 cholic or lithocholic acids, the loss of bile acids was tested at each step throughout the purification procedure by counting a 1.0-rn! aliquot of the fraction. The ammonium carbonate fraction from the ion-exchange step contained 85-99% of the added [14C]-24-cholic acid. The usual recoveries were 63-83% for the entire procedure.
GLC-MS.
Chromatograms representing a synthetic mixture of the common bile acids and a typical normal serum extract are depicted in Figure 1 . When the QF-1 stationary phase and the trifluoroacetate derivatives of the bile acids are used concurrently, the major bile acids as well as other constituents in a serum extract can be adequately resolved and measured.
For all the bile acids studied, a linear detector response was obtained down to 10 ng when a well-conditioned GC column was used. The curve for relative response ratio vs. microgram response (Figure 2) During GLC-MS, the first peak in the chromatogram ( Figure 2 ) gave an ion of weak intensity at m/e 486, which is consistent with the molecular weight for methyl trifluoroacetate of lithocholate. Ion fragments at m/e 471 (M-15), 455 (M-31), 372 (M-114), and 371 (M-115) were observed, corresponding, respectively, to losses of CH3., CH3O#{149}, CF3CO2H, the side chain; a fragment at m/e 318, corresponding to M -(TFA + ring A) was also present in the spectrum. Further significant fragments were m/e 230 [M -(115 + 114 + 27)]. Thus, we identified lithocholic acid in the serum of this healthy fasting person.
The mass spectrum for the third component in gas chromatograms did not give a parent ion at m/e 598; however, minor fragments were present at m/e 567 (M-31), 529 (M-69), and 484 (M-114). This pattern is similar to the mass spectrogram for the authentic methyl trifluoroacetate derivative of deoxycholate. A major ion at m/e 369 [M -(115 + 114)] was consistent with the elimination of the 12a-substituent and the side chain.
The mass spectra of the fourth and last chromatographic peaks ( Figure 2) were identified as esters of chenodeoxycholate and cholate. The parent ion at m/e 598 agrees with the calculated molecular weight for chermodeoxycholic acid, and ions at m/e 484 (M-114) and 369 (base peak) were also observed. The spectrum for cholate did not depict a parent ion; however a m/e 596 (M-114) and m/e 369 (base peak) were observed.
Measurement of bile acids in serum.
A quantitative study was conducted on 28 healthy fasting subjects, with use of this purification and gas chromatographic method.
As Table  2 shows, minute quantities of the major (primary and secondary) bile acids are present in peripheral serum.
Discussion
Using gas-liquid chromatographic techniques, The values obtained in total and individual serum bile acids in healthy persons are slightly lower than those previously reported (Table 2 ). This may be attributed, at least in part, to the exclusion of persons with occult hepatobiliary disease; our samples were included only after a careful history and physical examination, combined with normal values for serum bilirubin, alkaline phosphatases, aspartate aminotransferase, total protein, and albumin. Furthermore, the use of enzyme hydrolysis might be expected to reduce artifactual variations incurred by prolonged base hydrolysis of conjugate bile acids. The correction for loss of bile acids during purification of serum by employing a radiolabeled compound would also be expected to increase the reproducibility of analyses. These possibilities were not clearly incorporated in the work of other investigators (2, 3, 12 (2, 3, 16) . A knowledge of their levels may provide information concerning diseases of the liver and biliary tract, because the metabolism of these compounds is closely associated with the liver cell (17). Liver parenchyma and the biliary tree play a key role in the enterohepatic circulation of bile acids, and our studies indicate that only minute quantities escape into the systematic circulation in healthy, fasting subjects.
Further experimentation is necessary to determine whether a good correlation exists between serum bile acid levels and liver disease. Such a relationship would provide a sensitive clinical diagnostic test. Grant T01MH1224-O1.
